TL;DR
A study of over 1.1 million Californians confirms that flu shots reduced the likelihood of testing positive for influenza by 40% in the 2024-25 season. Vaccinated adults, especially seniors, also had a lower risk of flu-related death. The findings support ongoing vaccination efforts amid a high-severity flu season.
A new study confirms that receiving a flu shot during the 2024-25 season was associated with a 40% reduction in testing positive for influenza among over 1.1 million Californians, highlighting the vaccine’s role in mitigating infection risk during a high-severity season.
The study, published in JAMA Network Open, analyzed data from October 1, 2024, to May 31, 2025, a period marked by the highest influenza-related hospitalization rates in 24 years. It found that vaccinated individuals were significantly less likely to test positive for flu compared to unvaccinated peers. Specifically, adults aged 65 and older who contracted influenza were 29% less likely to die from flu-related causes if vaccinated, according to the researchers from the California Department of Public Health.
During this season, flu caused an estimated 610,000 to 1.3 million hospitalizations and 27,000 to 130,000 deaths nationwide, with 289 children dying from influenza, surpassing previous records from the 2009-2010 H1N1 epidemic. Public health experts continue to recommend annual flu vaccinations to reduce illness, hospitalization, and mortality risks, especially during severe seasons like this one.
Implications for Public Health and Vaccination Efforts
The findings underscore the importance of flu vaccination as an effective measure to prevent infection and reduce severe outcomes, including death, especially in vulnerable populations such as seniors. As the flu season reaches historic levels of severity, these results reinforce the need for widespread immunization campaigns to mitigate healthcare burdens and save lives.
flu shot vaccine for adults
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
High Severity and Impact of the 2024-25 Flu Season
The 2024-25 flu season has been characterized as high severity, with the highest hospitalization rates in over two decades. The CDC and public health officials have reported a surge in flu-related hospitalizations and deaths, with estimates indicating up to 1.3 million hospitalizations and over 130,000 deaths nationally. The season has also seen record flu-related pediatric deaths, exceeding previous peaks.
Previous research has consistently shown that flu vaccines reduce the risk of infection and severe disease. This study adds to that evidence, specifically quantifying the protective effect during this intense season, and supports ongoing vaccination efforts amid concerns about healthcare system strain.
“These findings are consistent with protection against severe and fatal influenza among people vaccinated against influenza.”
— study authors
influenza vaccination for seniors
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Uncertainties and Limitations of the Study
While the study confirms a strong association between flu vaccination and reduced infection rates, it is observational and cannot definitively establish causality. It is also unclear how factors like vaccine effectiveness variations, health behaviors, or access to healthcare influenced the results. Additionally, data on vaccination coverage and individual health status were not detailed in the summary.
flu prevention nasal spray
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Next Steps for Public Health and Research
Public health officials will likely continue promoting flu vaccination campaigns, emphasizing the benefits shown in this study. Further research may explore vaccine effectiveness in different age groups and populations, as well as strategies to improve coverage. Monitoring the ongoing flu season will help assess the long-term impact of vaccination efforts and inform future recommendations.
flu shot with high efficacy
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
Does the flu vaccine prevent all cases of influenza?
No, the flu vaccine reduces the risk of testing positive for influenza by about 40% during the 2024-25 season, but it does not prevent all cases. Effectiveness can vary based on factors like strain match and individual health.
Are older adults more protected by the flu vaccine?
Yes, the study found that adults aged 65 and older who received the vaccine were 29% less likely to die from flu-related causes, indicating increased benefits for this vulnerable group.
What about severe flu outcomes besides infection rates?
The study also indicated that vaccinated individuals had a lower risk of severe outcomes, such as death, especially among seniors, supporting vaccination as a key protective measure.
Is this season’s high severity typical or unusual?
The 2024-25 flu season is considered high severity, with the highest hospitalization rates in 24 years, making vaccination particularly important this year.
Will the findings influence future flu vaccination policies?
While the study reinforces the benefits of vaccination, policy changes will depend on ongoing data and public health priorities. Continued emphasis on vaccination is expected.
Source: Google Trends
